Brief: Biosyent signs distribution agreement for new cardiovascular products
25/05/2016 17:54
May 25 (Reuters) - Biosyent Inc:
* Biosyent signs exclusive distribution agreement for two
new cardiovascular products
* Intends to submit dossier seeking marketing approval of
products to Health Canada in 2016
* Forecasts that the new products will add approximately CAD
$20 million to overall revenue of company when they reach "peak
sales"
Source text for Eikon: urn:newsml:reuters.com:*:nMKW6hNvWa
Further company coverage: RX.V
((Bengaluru Newsroom; +1 646 223 8780;))
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid